Navigation Links
Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test

India Chosen as First Commercial Market to Demonstrate Test's Potential for

Rapid Uptake

OSLO and FOSTER CITY, California, November 10 /PRNewswire-FirstCall/ -- DiaGenic ASA (OSL: DIAG) and Applied Biosystems Inc. (NYSE: ABI) today announced the launch of BCtect(TM), a blood-based test for early detection of breast cancer. The test searches for a unique gene expression signature identified by DiaGenic using a custom TaqMan(R) Array manufactured for DiaGenic by Applied Biosystems. India was chosen as the first country for the introduction of BCtect(TM) after successful completion of a large study in the country.

The DiaGenic BCtect(TM) test addresses a significant medical need in India, where breast cancer is the second leading cause of death among women. The lack of a coordinated national screening program means that breast cancer is typically detected at a late stage, resulting in high mortality rates compared to Western countries. Last year alone, nearly 100,000 women in the country died from the disease. Breast cancer is also on the rise, with an estimated 250,000 new cases expected in India by 2015. A key problem has been the detection of only 10% of cases at an early stage, which lags far behind Western countries where detection rates reach as high as 65%.

Studies show there is more than a 90% chance of surviving breast cancer if detected at an early stage, whereas the mortality rate reaches 90% if this disease is caught at a very late stage. Clinical studies performed on a group of Indian women by DiaGenic have shown that the test can detect tumors early and accurately, in particular among younger (pre-menopausal) women and those with dense breasts.

DiaGenic launched BCtect(TM) at a special event in New Delhi. Speaking at the launch, DiaGenic CEO Erik Christensen, M.D. Ph.D., said that the company decided to launch the test in India because of the interest generated by its large clinical study across the country, which confirmed the test's gene signature is unaffected by ethnic variation.

"We hope that by introducing a test that uses peripheral blood rather than tissue from the actual breast, more women will be encouraged to come forward for testing," said Dr. Christensen. "In addition, we see BCtect(TM) filling a gap where mammography is not readily available."

More details on the selection of India as the first market for the new product were given by Praveen Sharma, Ph.D., co-founder of DiaGenic. "The results from our Indian study showed that the gene set, previously identified in Scandinavian and US cohorts, also had similar good diagnostic and predictive performance in the Indian population. BCtect(TM) is not affected by ethnic variation or menopausal state of the patient, allowing for widespread use to diagnose breast cancer at an early stage."

The TaqMan Array manufactured for DiaGenic by Applied Biosystems consists of 96 TaqMan(R) Gene Expression Assays pre-loaded multiple times on a 384-well micro fluidic card. These 384 simultaneous real-time PCR reactions are performed without the need to use liquid-handling robots or multichannel pipettors. The array is run on the Applied Biosystems 7900HT Fast Real-time PCR System by Labindia.

"We continue to demonstrate our commitment to providing scientists with the molecular tools they need to develop important diagnostics," said Peter Dansky, president of Applied Biosystems' functional analysis division.

"The TaqMan Arrays provide an ideal format for surveying gene expression markers based in their easy-to-use format, high sensitivity, and ability to facilitate standardization among laboratories for consistent and reliable results."

The DiaGenic BCtect(TM) breast cancer test will be marketed in India through Religare SRL (formerly known as SRL Ranbaxy), the largest laboratory chain in South East Asia. Sanjeev K. Chaudhry, M.D, CEO of SRL predicts high demand for the DiaGenic test.

"We believe that BCtect(TM) will provide the perfect incentive for women to take charge of their health and undergo regular check-ups," said Dr. Chaudhry. "Religare SRL will put in place intensive and extensive market-facing strategies to ensure rapid growth in the market, both locally and internationally, and will invest substantial amounts and efforts to inform the market on the availability of this new innovative test."

Corporate Inquiries

Erik Christensen, Managing Director

DiaGenic ASA, Grenseveien 92, NO-0663 Oslo, Norway

Tel +47-95939918 Email:

Media Inquiries

For Applied Biosystems:

Renaldo Juanso

Applied Biosystems

Tel +1-650-638-5354 Email:

SOURCE DiaGenic ASA and Applied Biosystems Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
(Date:10/9/2015)... Calif. , Oct. 9, 2015 AcelRx Pharmaceuticals, ... will be made at the annual European Society of Emergency ... to October 14 th , 2015 at the Lingotto Congress ... EuSEM is the largest meeting of emergency medicine practitioners in ... countries represented. Data from the previously announced phase ...
(Date:10/9/2015)... 2015 Ansun BioPharma announced a presentation at ... ) regarding the compassionate use of DAS181 under an ... who was co-infected with influenza and parainfluenza (Abstract # ... O 2 requirement was reduced and the patient,s ... go off the respirator on day 5. Between day ...
(Date:10/9/2015)... -- Der " JCA-Mauvernay Award   2015 ... und Dr.   Junko Takita    --> Der ... geht an Dr.   Yutaka Kondo und Dr.   ... JCA-Mauvernay Award   2015 " geht an Dr. ...    ™ , das weltweit tätige Schweizer Biopharmazieunternehmen, wird am ...
Breaking Medicine Technology:
... The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) ... to successfully open a patient,s blocked artery with a ... drill" to painlessly remove the plaque buildup which causes ... – conducted Wednesday by CVI Director of Endovascular Medicine ...
... HistoRx, the leader in quantitative immunohistochemistry, advances ... recent issuance of US patents covering key features ... results.  The U.S. Patent and Trademark Office has ... for standardization of digital microscopy instruments, methods required ...
Cached Medicine Technology:
(Date:10/9/2015)... ... October 09, 2015 , ... The American Osteopathic ... for Graduate Medical Education J. Michael Finley, DO, as the recipient of the ... for his impact on graduate medical education opportunities for osteopathic residents, and his ...
(Date:10/9/2015)... ... October 09, 2015 , ... With the FCPX LUT Vibrance pack from Pixel ... LUT is a Lookup Table that contains a mathematical formula for modifying an image. ... This pack comes with 60 vibrant CUBE LUT files. , Inspired by ...
(Date:10/9/2015)... ... ... Smoke alarms can save lives. In fact, according to the National Fire ... home fires in half. As part of Fire Prevention Week, Amica Insurance ... , Half of home fire deaths result from fires reported between 11 p.m. and ...
(Date:10/9/2015)... ... October 09, 2015 , ... Head Over Heels Athletic Arts gymnast, ... camp at the Karolyi Ranch in Huntsville, Texas on October 17-21. , "It's ... girls team head coach and executive director, said. “It's a stepping stone into the ...
(Date:10/9/2015)... , ... October 09, 2015 , ... The Asthma and ... US Centers for Disease Control and Prevention (CDC) to improve the knowledge and skills ... AAFA has been awarded a project by the CDC and allows AAFA to continue ...
Breaking Medicine News(10 mins):
... Kenya in the last week after an outbreak of Rift ... spokesman said on Thursday//. ,The contagious disease, which ... mid-December, has now spread to the east African country's central, ... 108 new human infections since last week. ,The ...
... Following on the news of the drop in cancer ... Society is launching the Great American Health Challenge// to ... their cancer risk. ,Many Americans are concerned ... 50 percent of cancer deaths could be prevented through ...
... Child Study Center has received a $3.5 million National ... an ongoing, multidisciplinary research program// on autism and related ... focuses on developmental aspects and outcomes for affected patients. ... manifestations of autism in infants at risk for the ...
... to some of today’s health issues, 100 percent fruit ... to certain diseases – concludes// a study by European ... to reduce risk compared to their whole fruit/vegetable counterparts ... the literature review. The researchers analyzed a variety of ...
... out that consuming the right type of fat may actually ... consume lesser quantities// of unsaturated fat and very little omega-3. ... age group of four was undertaken by scientists at Goteborg ... ,This study revealed that 23% of the children ...
... Japan came in for a lot of criticism this ... of describing women//. ,The minister was airing his views ... last Saturday, when the gaffe occurred. ,Quoting the minister: ... Because the number of birth-giving machines and devices is fixed, all ...
Cached Medicine News:
Medtronic neurosurgery external drainage and monitoring (EDM) products meet a variety of needs for CSF drainage and monitoring....
... CODMAN EDS 3 CSF External Drainage System was ... and physicians. The clinicians who work every day ... CODMAN EDS 3: ease-of-use in an integrated pole ... valve, accurate hydrostatic leveling from a unique laser ...
Monitorr ICP external CSF drainage and monitoring system with patient line one way valve....
... Specifically designed for neuro and skull ... craniotomies, cranioplasties, craniofacial surgery, pediatric neurosurgery, ... orbital, and skull base regions, neuro ... instruments and implants in one compact ...
Medicine Products: